Purchases and Sales Made in Q2 2024 in Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM) during Q2 2024. The information is specifically focused on institutions that hold shares of Axsome Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2024
Q2 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-317K- 95.23% |
$20.8M - $25.5M
|
15.9K
$1.65M
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-348K- 98.78% |
$22.9M - $28M
|
4.29K
$446K
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-390K- 34.14% |
$25.7M - $31.4M
|
753K
$78.3M
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-622K- 65.89% |
$40.9M - $50.1M
|
322K
$33.5M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-622K- 65.89% |
$40.9M - $50.1M
|
322K
$33.5M
|
|
Aug 14, 2024
Q2 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-646K- 58.46% |
$42.5M - $52M
|
459K
$47.7M
|